Recap: RAPT Therapeutics Q2 Earnings

RAPT Therapeutics RAPT reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

RAPT Therapeutics beat estimated earnings by 17.33%, reporting an EPS of $-0.62 versus an estimate of $-0.75.

Revenue was up $17 thousand from the same period last year.

Last quarter the company missed on EPS by $0.01 which was followed by a 8.96% increase in the share price the next day.

Here's a look at RAPT Therapeutics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.68	-0.66	-0.62	-0.67
EPS Actual	-0.69	-0.61	-0.63	-0.63
Revenue Estimate	220K	700K	780K	950K
Revenue Actual	641K	756K	966K	869K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for RAPT Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar